Search Results - G Specchia

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of “R... by M. Dargenio, C. Buquicchio, D. Pastore, L. Aprile, L. Ciuffreda, G. Greco, M. Delia, V. Federico, MP. Fina, D. Seripa, R. Matera, G. Tarantini, A. Maggi, L. Melillo, V. Pavone, P. Musto, G. Specchia, N. Di Renzo

    Published in Leukemia Research Reports (2025-01-01)
    Get full text
    Article


  2. 2

    P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN M... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  3. 3

    P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MUL... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  4. 4

    PB2200: CLONAL HEMATOPOIESIS AT THE CROSSROADS OF INFLAMMATORY BOWEL DISEASES AND HEMATOLOGICAL MALIGNANCIES: A BIOLOGICAL LINK? by C. Cumbo, F. Tarantini, A. Zagaria, L. Anelli, C. F. Minervini, N. Coccaro, G. Tota, L. Impera, E. Parciante, M. R. Conserva, I. Redavid, P. Carluccio, M. Delia, A. Giordano, C. Longo, T. Perrone, A. Russo Rossi, G. Specchia, P. Musto, F. Albano

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    DP093 | HYPOMETHYLATING AGENTS ALONE OR IN COMBINATION WITH VENETOCLAX IN VERY ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS: IS LESS BETTER THAN MORE? by F. Tarantini, V. Carluccio, M.A. Urbano, C. Pasciolla, C. Contento, L. Aprile, A.M. Carella, E. Vigna, M. Gentile, A. D’ambrosio, V.P. Gagliardi, M. Delia, I. Attolico, P. Carluccio, G. Tarantini, D. Pastore, A. Guarini, N. Di Renzo, A. Maggi, F. Frigeri, G. Specchia, P. Musto, F. Albano

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  6. 6

    P059 | SPLENOMEGALY IN DE NOVO ACUTE MYELOID LEUKEMIA IS ASSOCIATED WITH ASXL1 MUTATIONS AND PECULIAR GENE EXPRESSION AND CLINICAL PROFILE. by F. Tarantini, N. Coccaro, C. Cumbo, I. Redavid, L. Anelli, A. Zagaria, E. Parciante, M.R. Conserva, G. Tota, C. F. Minervini, A. Minervini, A. Mestice, V.P. Gagliardi, M. Delia, P. Carluccio, I. Attolico, A. Ricco, M.G. Macchia, M.F. Caratozzolo, F. Marzano, C. Telegrafo, S.N. Cox, B. Balech, A. Tullo, G. Specchia, P. Musto, F. Albano

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: